Cidara Therapeutics, Inc.

NasdaqCM:CDTX Stock Report

Market Cap: US$2.6b

Cidara Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CDTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Sep 25SellUS$29,797Nicole DavarpanahIndividual474US$62.86
26 Jun 25BuyUS$99,999,988RA Capital Management, L.P.Company2,272,727US$44.00
03 Jun 25BuyUS$73,896Chrysa MineoIndividual3,320US$23.44
11 Mar 25SellUS$38,940Leslie TariIndividual1,773US$21.96
11 Mar 25SellUS$36,542Shane WardIndividual1,664US$21.96

Insider Trading Volume

Insider Buying: CDTX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CDTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders129,2230.504%
Private Companies239,0700.932%
Hedge Funds1,527,9305.96%
VC/PE Firms4,676,94818.2%
Institutions19,077,88674.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 260.3%.

Top Shareholders

Top 25 shareholders own 81.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.3%
RA Capital Management, L.P.
3,365,523US$343.2m0%3.72%
6.03%
Point72 Asset Management, L.P.
1,527,930US$155.8m1,220%0.26%
5.17%
Vivo Capital, LLC
1,311,425US$133.8m91.7%8.0%
4.63%
Commodore Capital LP
1,175,000US$119.8m0%5.81%
4.45%
Paradigm Biocapital Advisors LP
1,128,613US$115.1m0%3.44%
4.37%
BlackRock, Inc.
1,107,668US$113.0m1,990%no data
4.34%
Adage Capital Management, L.P.
1,100,000US$112.2m11.1%0.18%
3.97%
TCG Crossover Management, LLC
1,005,901US$102.6m0%5.49%
3.81%
The Vanguard Group, Inc.
966,705US$98.6m89.7%no data
3.46%
Morgan Stanley
878,215US$89.6m10,600%0.01%
3.1%
BVF Partners L.P.
786,392US$80.2m-37.2%2.62%
3.03%
Darwin Global Management Limited
768,424US$78.4m0%1.97%
2.77%
Bain Capital Life Sciences Investors, LLC
703,080US$71.7m0%4.6%
2.52%
VR Management, LLC
639,088US$65.2m-39.2%2.96%
2.46%
Janus Henderson Group plc
625,000US$63.7m0%0.02%
1.97%
Vestal Point Capital, LP
500,000US$51.0m-0.9%1.95%
1.83%
Ikarian Capital, LLC
464,488US$47.4m86.6%11.08%
1.83%
Soleus Capital Management, L.P.
462,811US$47.2m0%2.28%
1.77%
Jefferies Financial Group Inc.
450,000US$45.9m0%0.63%
1.47%
Geode Capital Management, LLC
372,010US$37.9m577%no data
1.15%
Citadel Advisors LLC
290,951US$29.7m1.1%0.03%
1.06%
Caption Management, LLC
268,000US$27.3m0%2.17%
1.05%
StemPoint Capital LP
266,774US$27.2m0%5.89%
1.02%
Aberdeen Group Plc
259,916US$26.5m115%0.01%
0.99%
Sofinnova Investment, Inc.
251,031US$25.6m0%1.42%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 01:07
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cidara Therapeutics, Inc. is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Timothy ChiangBTIG
Chiara RussoCantor Fitzgerald & Co.
Eric SchmidtCantor Fitzgerald & Co.